AN2 Therapeutics, Inc. (ANTX)

NASDAQ:ANTX

US Market

ANTX

AN2 Therapeutics, Inc.

RESEARCH TOOLSreports

Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Ownership - Who Owns AN2 Therapeutics, Inc.?

106 Followers

AN2 Therapeutics, Inc. (ANTX) Ownership Overview

26.51% Insiders

3.34% Mutual Funds

41.18% Other Institutional Investors

2.97% ETFs

26.01% Public Companies and

Individual Investors

The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 47.48% of the company’s stock is owned by Institutional Investors, 26.51% is owned by Insiders, and 26.01% is owned by Public Companies and Individual Investors.

The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 44.52% of the company’s stock is owned by Institutional Investors, 26.51% is owned by Insiders, and 2.97% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	Sarah Joanne Williams	xxxxxxxxxxxxx	$347
Jan 07, 2026	Eizen Joshua M	xxxxxxxxxxxxx	$24923
Jan 07, 2026	Stephen David Prior	xxxxxxxxxxxxx	$6491
Jun 16, 2025	Braden Michael Leonard	xxxxxxxxxxxxx	$218000

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Sep 30, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$3398355

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,017,432	Insider	8.38%	13,729,316
	2,429,754	Insider	6.75%	11,055,381
	1,628,512	Insider	4.52%	7,409,730
	1,243,938	Insider	3.45%	5,659,918
Michael Rockefeller	993,671	Institution	2.76%	4,521,203
	985,504	Institution	2.74%	4,484,043
	935,028	Institution	2.60%	4,254,377
	551,418	Insider	1.53%	2,508,952
	207,543	Institution	0.58%	944,321
	207,499	Insider	0.58%	944,120

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	935,028	Institution	2.60%	4,254,377
	207,543	Institution	0.58%	944,321
	59,000	Institution	0.16%	268,450
	1,347	Institution	<0.01%	6,129

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	733,392	Institution	2.04%	2,508,201
Vanguard Extended Market ETF	252,112	Institution	0.70%	862,223
iShares Micro-Cap ETF	52,815	Institution	0.15%	225,520
Dimensional U.S. Small Cap ETF	26,415	Institution	0.07%	124,679
Dimensional U.S. Core Equity 2 ETF	3,416	Institution	<0.01%	16,124

FAQ

Who Owns AN2 Therapeutics, Inc. (ANTX)?

According to the latest TipRanks data, approximately 41.18% of the company's stock is held by institutional investors, 26.51% is held by insiders, and 26.01% is held by retail investors.

What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 41.18% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.

What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 26.01% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.

Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?

Braden Michael Leonard owns the most shares of AN2 Therapeutics, Inc. (ANTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.